Monitor for TSXV approval and announcement of effective date. A reverse split may temporarily boost share price but often signals financial distress; watch for follow-on dilution or capital raises.
Price Chart
Executive Summary
XORTX Therapeutics announced shareholder approval for a reverse stock split of up to 5:1 to comply with NASDAQ's $1.00 minimum bid requirement by April 13, 2026. The consolidation aims to avoid delisting and will reduce outstanding shares from ~6.96M to ~1.39M, pending TSXV approval.
Key Facts
- Shareholders approved a reverse stock split of up to 5 pre-consolidation shares into 1 post-consolidation share.
- Current shares outstanding: 6,962,218; expected post-consolidation: ~1,392,443.
- Purpose: comply with NASDAQ’s $1.00 minimum bid requirement and avoid delisting.
- TSXV approval is required; no name change will accompany the consolidation.
- Fractional shares will be rounded up if ≥0.5 or cancelled if <0.5.
- Deadline for NASDAQ compliance: 10 consecutive days above $1.00 by April 13, 2026.
Financial Impact
No direct financial impact, but structural change to share count and price to avoid delisting.
Risk Factors
- Failure to meet NASDAQ’s $1.00 requirement by April 13, 2026, could lead to delisting.
- Reverse split may negatively impact investor sentiment and trading liquidity.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 press release from GlobeNewswire.
| Document | Accession Number |
|---|---|
| PRESS-RELEASE Data (Synthetic) | press-3261811 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 8, 2026 18d ago | 6-K | $1.41 | awaiting T+20 | — | $1.03 (−26.95%) |
Sep 18, 2026 5w ago | 6-K | $1.92 $1.24 | ▼ −35.42% | ▼ −35.62% | $1.03 (−46.35%) |
Sep 18, 2026 5w ago | Press Release | $1.92 $1.24 | ▼ −35.42% | ▼ −35.62% | $1.03 (−46.35%) |
Sep 4, 2026 7w ago | 6-K | $2.31 $1.70 | ▲ +26.41% | ▲ +27.01% | $1.03 (+55.41%) |
Aug 28, 2026 8w ago | 6-K | $2.34 $1.71 | ▼ −26.86% | ▼ −27.12% | $1.03 (−55.95%) |
Aug 3, 2026 12w ago | 6-K | $2.16 $2.16 | · 0.00% | ▲ +1.24% | $1.03 (−52.31%) |
Jul 29, 2026 12w ago | 6-K | $2.06 $2.22 | ▲ +7.67% | ▲ +2.65% | $1.03 (−50.00%) |
Jun 15, 2026 19w ago | 6-K | $2.19 $2.03 | ▼ −7.31% | ▼ −6.56% | $1.03 (−52.97%) |
Jun 12, 2026 19w ago | 6-K | $2.19 $2.03 | ▼ −7.31% | ▼ −6.56% | $1.03 (−52.97%) |
May 19, 2026 23w ago | 6-K / PRESS-RELEASE | $2.32 $2.15 | ▲ +7.33% | ▲ +8.31% | $1.03 (+55.60%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers